Auflistung nach Autor "Nikolopoulou, G."
Anzeige der Dokumente 1-4 von 4
-
Epidemiology and natural course of hepatitis C in Greece: Results of the nationwide HEPNET Greece Cohort Study
Raptopoulou, M.; Tzoumakliotis, D.; Nikolopoulou, G.; Skoutelis, A.; Dalekos, G.; Dimopoulou, M.; Angelidou, K.; Avgerinos, A.; Chatzis, G.; Manotakopoulos, S. (2006) -
HEPATOCELLULAR CARCINOMA (HCC) RISK IN HBeAg-NEGATIVE CHRONIC HEPATITIS B (CHBe-) WITH OR WITHOUT CIRRHOSIS TREATED WITH ENTECAVIR: RESULTS OF THE NATIONWIDE HepNet.Greece COHORT STUDY
Papatheodoridis, G.; Manolakopoulos, S.; Touloumi, G.; Nikolopoulou, G.; Raptopoulou-Gigi, M.; Gogos, C.; Vafiadis-Zouboulis, I.; Karamanolis, D.; Chouta, A.; Ilias, A.; Drakoulis, C.; Mimidis, K. M.; Ketikoglou, I.; Manesis, E.; Mela, M.; Hatzis, G.; Dalekos, G.; HepNet Greece Study, Grp (2013) -
Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort
Papatheodoridis, G. V.; Manolakopoulos, S.; Touloumi, G.; Nikolopoulou, G.; Raptopoulou-Gigi, M.; Gogos, C.; Vafiadis-Zouboulis, I.; Karamanolis, D.; Chouta, A.; Ilias, A.; Drakoulis, C.; Mimidis, K.; Ketikoglou, I.; Manesis, E.; Mela, M.; Hatzis, G.; Dalekos, G. N. (2015)Hepatocellular carcinoma (HCC) may still develop in chronic hepatitis B (CHB) patients treated with lamivudine. Whether HCC rates are comparable in patients treated with the current first-line antivirals remains uncertain. ... -
Prevalence and clinical course of hepatitis delta infection in Greece: A 13-year prospective study
Manesis, E. K.; Vourli, G.; Dalekos, G.; Vasiliadis, T.; Manolaki, N.; Hounta, A.; Koutsounas, S.; Vafiadis, I.; Nikolopoulou, G.; Giannoulis, G.; Germanidis, G.; Papatheodoridis, G.; Touloumi, G. (2013)Background & Aims: Hepatitis D virus (HDV) has decreased in Europe, but recent reports indicate a rising trend. We report the epidemiological changes, clinical progress, and effect of treatment on the natural course of HDV ...